Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Preference for Berodual Respimat vs Berodual MA in Asthma and COPD
NCT02173795Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fenoterol + ipratropium in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2002; status: completed.
02
Drugs
fenoterol + ipratropium
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02173795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173795.